Dabur India Ltd
NSE:DABUR
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
495.2
667.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dabur India Ltd
Dabur India Ltd
Cost of Revenue
Dabur India Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dabur India Ltd
NSE:DABUR
|
Cost of Revenue
-₹64B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-6%
|
|
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
Cost of Revenue
-₹62B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
Cost of Revenue
-₹296.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Gillette India Ltd
NSE:GILLETTE
|
Cost of Revenue
-₹11B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-3%
|
|
|
C
|
Colgate-Palmolive (India) Ltd
NSE:COLPAL
|
Cost of Revenue
-₹17.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
|
Procter & Gamble Hygiene and Health Care Ltd
NSE:PGHH
|
Cost of Revenue
-₹15.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
Dabur India Ltd
Glance View
Dabur India Ltd., rooted deeply in the rich tapestry of ancient Ayurvedic traditions, has organically evolved into one of India's leading FMCG companies. Established in the late 19th century by Dr. S.K. Burman, Dabur began its journey with a mission to provide effective and affordable healthcare solutions. Over the years, the company has skillfully blended age-old wisdom with modern scientific research to craft a diverse product portfolio ranging from personal care products, health supplements, and digestives to over-the-counter medications and foods. This unique approach harnessing the virtues of natural ingredients has not only won consumer trust but also solidified Dabur's standing as a pioneer in herbal and natural products. The engine that drives Dabur’s financial performance is its expansive product range, complemented by an extensive distribution network that spans both urban and rural India. By strategically tapping into various sectors such as health care, personal care, and foods, Dabur has effectively spread its revenue streams, reducing dependency on any single category. With flagship brands like Dabur Chyawanprash, Dabur Honey, Vatika, and Real, the company enjoys strong brand equity. It continuously invests in marketing and innovation to expand its reach and engage a broader audience. Additionally, its export operations cater to the global demand for natural and holistic products, further bolstering revenue. Dabur's ability to adapt and innovate while staying true to its natural-centric philosophy ensures its robust presence in both domestic and international markets.
See Also
What is Dabur India Ltd's Cost of Revenue?
Cost of Revenue
-64B
INR
Based on the financial report for Sep 30, 2024, Dabur India Ltd's Cost of Revenue amounts to -64B INR.
What is Dabur India Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%
Over the last year, the Cost of Revenue growth was 1%. The average annual Cost of Revenue growth rates for Dabur India Ltd have been -6% over the past three years , -8% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
